Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Equisetum giganteum aqueous extract (AEGH) is a botanical extract derived from the giant horsetail plant, a species used in traditional medicine primarily as a diuretic. The extract demonstrates **anti-inflammatory potential** in acute inflammation models by reducing articular nociception, decreasing leukocyte migration, and inhibiting lymphocyte proliferation. AEGH exhibits **immunomodulatory effects** on both B and T lymphocytes, with action independent of cytotoxicity. The mechanism of action appears to involve inhibition of pro-inflammatory cytokine production and modulation of immune cell activity. The plant contains various bioactive constituents including alkaloids, flavonoids, phenols, phytosterols, saponins, sterols, silicic acid, tannins, triterpenoids, and volatile oils. Research suggests the extract may have applications in treating inflammation, genitourinary diseases, wound healing, and rheumatic diseases. Studies in antigen-induced arthritis models in mice demonstrated significant reduction in pain and inflammatory markers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on equisetum giganteum aqueous extract.